Filings & corporate actions
84 results filed
CSVNext results · Q2 FY27
Expected 8 Nov 2026 – 12 Nov 2026
Estimate: filed 39–43 days after quarter end, last 5 times
Dividend
₹1.00 per share · last 24 Jul 2026
2026
- 6 AugresultsResults · Q1 FY27 · consolidated and standalone+3.8%NSE
- 24 JuldividendDividend · ₹1.00 per share+0.5%
- 21 JulshareholdingShareholding · 30 Jun 2026+1.9%NSE
- 22 MayresultsResults · Q4 FY26 · consolidated and standalone+1.0%NSE
- 13 AprshareholdingShareholding · 31 Mar 2026+0.3%NSE
- 13 FebresultsResults · Q3 FY26 · consolidated and standalone-0.1%NSE
- 14 JanshareholdingShareholding · 31 Dec 2025+0.2%NSE
Reaction to results · all yearsrose on day 0 in 30 of 76 CSV
| Quarter | Filed | Day 0 | +5D | +20D | Rel vol |
|---|---|---|---|---|---|
| Q1 FY27 | 6 Aug 2026 | +3.8% | +1.0% | -1.6% | 3.6× |
| Q4 FY26 | 22 May 2026 | +1.0% | -3.2% | +1.2% | 1.4× |
| Q3 FY26 | 13 Feb 2026 | -0.1% | +0.3% | -10.5% | 1.2× |
| Q2 FY26 | 11 Nov 2025 | -1.8% | -6.5% | -13.6% | 3.3× |
| Q1 FY26 | 6 Aug 2025 | +3.0% | +8.6% | +9.9% | 6.4× |
| Q4 FY25 | 20 May 2025 | -1.0% | +4.6% | +11.8% | 1.2× |
| Q3 FY25 | 7 Feb 2025 | -3.6% | -5.6% | -3.7% | 1.6× |
| Q2 FY25 | 8 Nov 2024 | +0.5% | +6.0% | +15.0% | 0.6× |
| Q1 FY25 | 6 Aug 2024 | -2.1% | +5.1% | +12.9% | 2.0× |
| Q4 FY24 | 23 May 2024 | -1.5% | +1.3% | +3.4% | 2.3× |
| Q3 FY24 | 7 Feb 2024 | -2.5% | -4.3% | -15.8% | 1.5× |
| Q2 FY24 | 10 Nov 2023 | -0.3% | +0.3% | +7.4% | 0.4× |
| Q1 FY24 | 4 Aug 2023 | -4.3% | -7.3% | -1.1% | 2.7× |
| Q4 FY23 | 24 May 2023 | -0.5% | -4.9% | +7.1% | 2.8× |
| Q3 FY23 | 10 Feb 2023 | -3.7% | -1.7% | -7.2% | 1.3× |
| Q2 FY23 | 11 Nov 2022 | +7.7% | +0.4% | +2.0% | 17.7× |
| Q1 FY23 | 5 Aug 2022 | +1.8% | +11.1% | +9.2% | 2.7× |
| Q4 FY22 | 25 May 2022 | -1.5% | -0.1% | -2.4% | 1.2× |
| Q3 FY22 | 11 Feb 2022 | -0.1% | -1.1% | -2.9% | 2.5× |
| Q2 FY22 | 12 Nov 2021 | +7.4% | +7.9% | +10.0% | 6.4× |
| Q1 FY22 | 13 Aug 2021 | +9.0% | +18.4% | +16.0% | 5.8× |
| Q4 FY21 | 29 May 2021 | -1.1% | +2.7% | +3.3% | 0.7× |
| Q3 FY21 | 5 Feb 2021 | +0.7% | -2.4% | +6.3% | 0.7× |
| Q2 FY21 | 13 Nov 2020 | +5.1% | +5.4% | +17.1% | 3.5× |
| Q1 FY21 | 14 Aug 2020 | 0.0% | +2.7% | -1.8% | 0.8× |
| Q4 FY20 | 17 Jun 2020 | -0.5% | +1.3% | +5.7% | 1.7× |
| Q3 FY20 | 14 Feb 2020 | -3.4% | -1.0% | -22.1% | 0.4× |
| Q2 FY20 | 6 Nov 2019 | +2.7% | -2.0% | -6.5% | 5.9× |
| Q1 FY20 | 6 Aug 2019 | -1.1% | +3.9% | +4.9% | 2.9× |
| Q4 FY19 | 25 May 2019 | +2.2% | -0.4% | +2.8% | 4.1× |
| Q3 FY19 | 26 Feb 2019 | -0.7% | -1.5% | +0.4% | 2.9× |
| Q2 FY19 | 22 Nov 2018 | -0.1% | +0.8% | -7.9% | 0.4× |
| Q1 FY19 | 31 Aug 2018 | -1.4% | -1.5% | -8.3% | 0.9× |
| Q4 FY18 | 10 Jul 2018 | -0.4% | +1.0% | +4.1% | 0.4× |
| Q2 FY18 | 16 Mar 2018 | -1.5% | -5.3% | -7.1% | 0.2× |
| Q3 FY18 | 16 Mar 2018 | -1.5% | -5.3% | -7.1% | 0.2× |
| Q1 FY18 | 7 Aug 2017 | -1.3% | -9.8% | -8.5% | 0.9× |
| Q4 FY17 | 6 Jun 2017 | +1.6% | -2.1% | -15.0% | 1.2× |
| Q3 FY17 | 17 Feb 2017 | +0.5% | -1.4% | -10.8% | 0.5× |
| Q2 FY17 | 18 Nov 2016 | -0.6% | +9.4% | +13.6% | 0.5× |
| Q1 FY17 | 3 Oct 2016 | +4.4% | +4.1% | +4.0% | 1.6× |
| Q4 FY16 | 29 May 2016 | -2.8% | -0.3% | -4.9% | 1.3× |
| Q3 FY16 | 8 Feb 2016 | +0.4% | -7.1% | +1.8% | 0.4× |
| Q2 FY16 | 4 Nov 2015 | +1.7% | +0.2% | +10.6% | 2.7× |
| Q1 FY16 | 6 Aug 2015 | -1.7% | -6.6% | -20.1% | 1.7× |
| Q3 FY15 | 18 Feb 2015 | +4.8% | +13.3% | +13.7% | 2.1× |
| Q2 FY15 | 20 Nov 2014 | -2.5% | -4.8% | -8.3% | 1.2× |
| Q1 FY15 | 12 Aug 2014 | -0.4% | +5.5% | +5.5% | 1.3× |
| Q4 FY14 | 29 May 2014 | -3.1% | +5.4% | +10.2% | 1.0× |
| Q3 FY14 | 12 Feb 2014 | -1.4% | -3.7% | -3.7% | 0.9× |
| Q2 FY14 | 15 Nov 2013 | +1.0% | +4.4% | +1.8% | 1.0× |
| Q1 FY14 | 8 Aug 2013 | +1.8% | -0.1% | +1.9% | 1.1× |
| Q4 FY13 | 8 Jun 2013 | +0.4% | +1.7% | -1.6% | 0.5× |
| Q3 FY13 | 13 Feb 2013 | +1.1% | +0.2% | -0.1% | 9.8× |
| Q2 FY13 | 21 Nov 2012 | +1.9% | +9.9% | +15.9% | 4.5× |
| Q1 FY13 | 28 Aug 2012 | -1.1% | -0.9% | +9.1% | 0.7× |
| Q4 FY12 | 1 Jun 2012 | +2.6% | +4.0% | +5.3% | 1.0× |
| Q3 FY12 | 10 Feb 2012 | -1.0% | +4.9% | -1.8% | 0.9× |
| Q2 FY12 | 15 Nov 2011 | -1.6% | -6.9% | -18.5% | 0.9× |
| Q1 FY12 | 12 Aug 2011 | -3.0% | -6.1% | -6.0% | 0.8× |
| Q4 FY11 | 31 May 2011 | -0.4% | +1.0% | -3.1% | 0.6× |
| Q3 FY11 | 8 Feb 2011 | +5.1% | +10.0% | +8.9% | 4.2× |
| Q2 FY11 | 3 Nov 2010 | +1.5% | +2.7% | -6.0% | 1.8× |
| Q1 FY11 | 6 Aug 2010 | +0.6% | +1.3% | +4.0% | 2.2× |
| Q4 FY10 | 28 May 2010 | -1.3% | -6.2% | +2.7% | 1.4× |
| Q3 FY10 | 22 Jan 2010 | +2.0% | +5.9% | +9.7% | 1.0× |
| Q2 FY10 | 27 Oct 2009 | -2.4% | -6.9% | +1.2% | 1.7× |
| Q1 FY10 | 24 Jul 2009 | +1.0% | +9.8% | +16.5% | 2.1× |
| Q4 FY09 | 30 Jun 2009 | -4.6% | -11.3% | +1.7% | 1.1× |
| Q3 FY09 | 20 Jan 2009 | -4.9% | -5.5% | -5.4% | 0.4× |
| Q2 FY09 | 29 Oct 2008 | +4.9% | +19.5% | +12.0% | 2.1× |
| Q1 FY09 | 30 Jul 2008 | -0.1% | +5.3% | +11.9% | 1.0× |
| Q4 FY08 | 30 Jun 2008 | -4.8% | -2.9% | -2.2% | 0.2× |
| Q3 FY08 | 23 Jan 2008 | -8.1% | -0.7% | -12.8% | 0.5× |
| Q2 FY08 | 30 Oct 2007 | -2.3% | -8.0% | +2.9% | 1.6× |
| Q1 FY08 | 31 Jul 2007 | -6.4% | -3.1% | -12.8% | 0.4× |
| Average | -0.1% | +0.7% | +0.7% | ||
Close-to-close from the session before the filing could trade. Day 0 is the first session after it.
Growth · Q1 FY27
CSVRevenue YoY+17.5%
Profit YoY+2.3%
Interest cost YoY+48.8%
Revenue QoQ+7.6%
Profit QoQ+0.6%
| CAGR | 2Y | 3Y | 4Y | 5Y | 6Y | 7Y |
|---|---|---|---|---|---|---|
| Revenue | +15.8% | +13.7% | +13.2% | +14.5% | +15.0% | +11.0% |
| Profit | +24.1% | +19.8% | +21.3% | +13.7% | — | — |
Key data
CSVOpen770.00
Day range756.30 – 770.20
52-week range745.35 – 1,104.30
From 52w high-30.8%
RSI (14)22.4
ATR (14)24.29
Volume12.47L
Avg volume (20D)18.22L
Rel volume0.68×
Volatility (1Y)26.9%
Turnover₹95.3Cr
SMA 50 / 200898.42 / 908.58
Delivery percentage
Latest · 6 Oct 202652.5%
20-day avg53.9%
1-year avg55.6%
Percentile (own history)39th
Range18.1–90.8%
Sessions1,731
Over the last 20 sessions FORTIS settled 53.9% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 55.6%. The latest session ranks higher than 39% of the 1,731 sessions on record for it.
What delivery percentage measuresScan the whole market on delivery
IndustryHospital
Performance returns
CSV| 1D | 1W | 1M | 3M | 6M | 1Y | |
|---|---|---|---|---|---|---|
| Price | +0.03% | -8.03% | -16.73% | -21.39% | -3.14% | -18.09% |
Valuation
CSVMarket cap₹57,679 Cr
P/E (TTM)53.9
EPS (TTM)14.18
Shares outstanding75.50Cr
Listed9 May 2007
Ownership
CSVPromoter31.17%
Promoter Δ QoQ0.00 pp
Public68.83%
FII25.20%
DII32.23%
Pledged0.00%
Quarterly results · consolidated
CSV| Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|
| Revenue (₹ Cr) | 2,331.4 | 2,265.0 | 2,364.7 | 2,545.0 |
| YoY chg | +17.3% | +17.5% | +17.8% | +17.5% |
| Net profit (₹ Cr) | 328.8 | 197.4 | 271.2 | 272.8 |
| YoY chg | +70.3% | -22.4% | +44.2% | +2.3% |
| Net margin | 14.1% | 8.7% | 11.5% | 10.7% |
| EPS | 4.26 | 2.57 | 3.52 | 3.53 |
Shareholding over time
CSVBy quarter
30 Jun 2026 · promoter 31.17% · public 68.83%2021-092026-06
- Promoter
- Public and others
- Promoter
- 31.17%
- Public
- 68.83%
- Promoter change
- 0.00 pp
- Filed
- 21 Jul 2026
- FII
- 25.20%
- DII
- 32.23%
- Promoter pledged
- 0.00%
Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.
Financials · quarterly statement
CSV₹ crore, as filed
| Q2 FY24 | Q3 FY24 | Q4 FY24A | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25A | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26A | Q1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 1,770.0 | 1,679.7 | 1,785.9 | 1,858.9 | 1,988.4 | 1,928.3 | 2,007.2 | 2,166.7 | 2,331.4 | 2,265.0 | 2,364.7 | 2,545.0 | |
| Other income | 13.5 | 6.8 | 9.8 | 13.0 | 13.2 | 20.9 | 19.8 | 15.4 | 22.6 | 8.3 | 4.4 | 14.5 | |
| Total income | 1,783.5 | 1,686.5 | 1,795.7 | 1,871.9 | 2,001.6 | 1,949.2 | 2,027.0 | 2,182.1 | 2,354.0 | 2,273.3 | 2,369.1 | 2,559.5 | |
| Total expenses | 1,555.7 | 1,515.6 | 1,531.8 | 1,642.7 | 1,685.0 | 1,695.6 | 1,741.5 | 1,847.1 | 1,955.8 | 1,965.2 | 2,038.6 | 2,210.2 | |
| └ Finance costs | 31.8 | 33.0 | 34.7 | 35.3 | 36.4 | 45.2 | 67.6 | 69.6 | 74.9 | 85.7 | 84.3 | 80.4 | |
| └ Depreciation | 84.1 | 86.9 | 92.2 | 91.0 | 95.1 | 97.3 | 102.2 | 101.5 | 105.8 | 120.1 | 122.0 | 121.9 | |
| Profit before tax | 231.4 | 178.6 | 267.1 | 229.5 | 256.8 | 277.3 | 231.9 | 347.7 | 421.7 | 262.2 | 318.0 | 358.8 | |
| Tax expense | 48.8 | 48.9 | 68.2 | 56.1 | 68.0 | 25.1 | 48.5 | 83.8 | 96.6 | 68.3 | 53.0 | 90.4 | |
| Net profit | 183.9 | 134.2 | 203.1 | 174.0 | 193.1 | 254.3 | 188.0 | 266.8 | 328.8 | 197.4 | 271.2 | 272.8 | |
| EPS | 2.30 | 1.78 | 2.37 | 2.20 | 2.34 | 3.28 | 2.44 | 3.45 | 4.26 | 2.57 | 3.52 | 3.53 | |
| Net margin | 10.39% | 7.99% | 11.37% | 9.36% | 9.71% | 13.19% | 9.37% | 12.31% | 14.10% | 8.72% | 11.47% | 10.72% | |
| PBT margin | 13.08% | 10.63% | 14.95% | 12.34% | 12.92% | 14.38% | 11.55% | 16.04% | 18.09% | 11.57% | 13.45% | 14.10% | |
| Tax rate | 21.09% | 27.39% | 25.55% | 24.44% | 26.47% | 9.05% | 20.93% | 24.10% | 22.90% | 26.05% | 16.67% | 25.19% |
A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 6 Aug 2026.
FORTIS at a glance
- FORTIS closed at ₹764 on 6 Oct 2026, +0.03% on the day, -18.1% over one year, 30.8% below its 52-week high of ₹1,104.3.
- Delivery was 52.5% of traded quantity on 6 Oct 2026, the 39th percentile of its own 1,731 sessions with a reading (20-session average 53.9%, 1-year average 55.6%).
- Market capitalisation is ₹57,679 crore at a trailing P/E of 53.9 (trailing EPS ₹14.18).
- Q1 FY27 results (consolidated, filed 6 Aug 2026): revenue ₹2,545 crore (+17.5% year on year), net profit ₹273 crore (+2.3%); the price moved +3.8% on the first session after.
- Promoters held 31.17% at 30 Jun 2026, unchanged on the previous filing.
- Q2 FY27 results are expected between 8 Nov 2026 and 12 Nov 2026, going by past filing dates — an estimate, not an announcement.
About
CSVMacro sectorHealthcare
Basic industryHospital
ISININE061F01013
SeriesEQ
Listed9 May 2007
History from9 May 2007
Sessions4,808
Turnover rank#202
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.
More in Healthcare Services
CSV- APOLLOHOSPApollo Hospitals Enterprise Limited7,914.50-0.88%
- MAXHEALTHMax Healthcare Institute Limited902.50-1.58%
- YATHARTHYatharth Hospital & Trauma Care Services Limited1,058.80+5.56%
- ASTERDMAster DM Quality Care Limited684.70-0.98%
- MANIPALHOSManipal Health Enterprises Limited690.50+3.52%
- LALPATHLABDr. Lal Path Labs Ltd.1,964.20-0.36%
- ARTEMISMEDArtemis Medicare Services Limited318.35-1.77%
- NEPHROPLUSNephrocare Health Services Limited634.55-0.49%
- GKSLGujarat Kidney And Super Speciality Limited193.62+1.72%
- KIMSKrishna Institute of Medical Sciences Limited693.40-1.71%
- NHNarayana Hrudayalaya Ltd.1,723.80+0.08%
- MEDANTAGlobal Health Limited1,300.80-2.39%
All Healthcare Services stocks on the NSEAll Healthcare stocks on the NSE